Modifying the surfaces of LPXs with hydrophilic PEG chains prevents them from aggregating in vitreous. In this way, LPXs are obtained that can freely move in vitreous, an absolute criterion for reaching the retina after intravitreal injection.
No takes yet. Share an insight, caveat, or question.
Peeters et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: